Benzinga

España
Italia
대한민국
日本
Français
Benzinga Edge
Benzinga Research
Benzinga Pro

  • Get Benzinga Pro
  • Data & APIs
  • Events
  • Premarket
  • Advertise
Contribute
España
Italia
대한민국
日本
Français

Benzinga

  • Premium Services
  • Financial News
    Latest
    Earnings
    Guidance
    Dividends
    M&A
    Buybacks
    Interviews
    Management
    Offerings
    IPOs
    Insider Trades
    Biotech/FDA
    Politics
    Healthcare
    Small-Cap
  • Markets
    Pre-Market
    After Hours
    Movers
    ETFs
    Options
    Cryptocurrency
    Commodities
    Bonds
    Futures
    Mining
    Real Estate
    Volatility
  • Ratings
    Analyst Color
    Downgrades
    Upgrades
    Initiations
    Price Target
  • Investing Ideas
    Trade Ideas
    Long Ideas
    Short Ideas
    Technicals
    Analyst Ratings
    Analyst Color
    Latest Rumors
    Whisper Index
    Stock of the Day
    Best Stocks & ETFs
    Best Penny Stocks
    Best S&P 500 ETFs
    Best Swing Trade Stocks
    Best Blue Chip Stocks
    Best High-Volume Penny Stocks
    Best Small Cap ETFs
    Best Stocks to Day Trade
    Best REITs
  • Money
    Investing
    Cryptocurrency
    Mortgage
    Insurance
    Yield
    Personal Finance
    Forex
    Startup Investing
    Real Estate Investing
    Prop Trading
    Credit Cards
    Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Connect With Us
facebookinstagramlinkedintwitteryoutubeblueskymastodon
About Benzinga
  • About Us
  • Careers
  • Advertise
  • Contact Us
Market Resources
  • Advanced Stock Screener Tools
  • Options Trading Chain Analysis
  • Comprehensive Earnings Calendar
  • Dividend Investor Calendar and Alerts
  • Economic Calendar and Market Events
  • IPO Calendar and New Listings
  • Market Outlook and Analysis
  • Wall Street Analyst Ratings and Targets
Trading Tools & Education
  • Benzinga Pro Trading Platform
  • Options Trading Strategies and News
  • Stock Market Trading Ideas and Analysis
  • Technical Analysis Charts and Indicators
  • Fundamental Analysis and Valuation
  • Day Trading Guides and Strategies
  • Live Investor Events
  • Pre-market Stock Analysis and News
  • Cryptocurrency Market Analysis and News
Ring the Bell

A newsletter built for market enthusiasts by market enthusiasts. Top stories, top movers, and trade ideas delivered to your inbox every weekday before and after the market closes.

  • Terms & Conditions
  • Do Not Sell My Personal Data/Privacy Policy
  • Disclaimer
  • Service Status
  • Sitemap
© 2026 Benzinga | All Rights Reserved
April 25, 2022 12:03 PM 4 min read

Mid-Day Market Update: Crude Oil Tumbles Over 6%; Nkarta Shares Spike Higher

by Lisa Levin Benzinga Editor
Follow

U.S. stocks traded lower midway through trading, with the Dow Jones dropping more than 400 points on Monday.

The Dow traded down 1.27% to 33,380.67 while the NASDAQ fell 0.85% to 12,730.19. The S&P also fell, dropping, 1.57% to 4,204.92.

Also check this: Executives Buy More Than $70M Of 4 Stocks


Leading and Lagging Sectors


Communication services shares rose by 0.8% on Monday. Meanwhile, top gainers in the sector included Redbox Entertainment Inc. (NASDAQ:RDBX), up 21% and VTEX (NYSE:VTEX) up 7%.


In trading on Friday, energy shares dipped by 5%.


Top Headline


Coca-Cola Co (NYSE:KO) reported better-than-expected earnings for its first quarter on Friday.

Coca-Cola reported first-quarter FY22 net revenue growth of 16% year-on-year, to $10.49 billion, beating the consensus of $9.83 billion. Adjusted EPS of $0.64 beat the analyst consensus of $0.58.

Coca-Cola expects the suspension of Russian business to affect 1% - 2% of its net revenue and operating income. The company still sees FY22 organic revenue growth of 7% - 8% and comparable EPS growth of 5% - 6%.

 

Equities Trading UP


Nkarta, Inc. (NASDAQ:NKTX) shares shot up 93% to $15.02 after the company announced Phase 1 data from independent dose finding studies of its two lead chimeric antigen receptor natural killer cell therapy candidates, NKX101 and NKX019.


Shares of Sunshine Biopharma, Inc. (NASDAQ:SBFM) got a boost, shooting 29% to $4.29 after the company reported it filed a provisional patent application in the US covering the recently communicated mRNA molecules found in pre-clinical trials to be effective at destroying cancer cells grown in culture.


Ardelyx, Inc. (NASDAQ:ARDX) shares were also up, gaining 30% to $0.9760 after the company reported it received an interim response from the OND, CDER and FDA for the company's second level of appeal of the Complete Response Letter for XPHOZAH.

 

Equities Trading DOWN


Shares of ToughBuilt Industries, Inc. (NASDAQ:TBLT) were down 44% to $14.81. ToughBuilt Industries reported a 1-for-150 reverse stock split as part of Nasdaq compliance plan.


Clarus Therapeutics Holdings, Inc. (NASDAQ:CRXT) was down, falling 54% to $0.8250. Clarus Therapeutics reported pricing of upsized underwritten public offering at $1.10 per share.

Also check out: 2 Stocks Under $5 Insiders Are Aggressively Buying


Commodities

In commodity news, oil traded down 6.5% to $95.39, while gold traded down 2% to $1,895.00.


Silver traded down 2.9% Monday to $23.56 while copper fell 3.4% to $4.4280.



Euro zone


European shares were lower today. The eurozone’s STOXX 600 dropped 1.38%, London’s FTSE 100 declined 1.49%, while Spain’s IBEX 35 Index fell 0.35%. The German DAX fell 1.04%, French CAC 40 fell 1.42% and Italy’s FTSE MIB Index fell 1.11%.

Construction output in the Eurozone climbed 9.4% year-over-year in February, following a revised 4.4% growth in the prior month. The Ifo Business Climate indicator for Germany increased to 91.8 in April from March’s 14-month low level of 90.8, while Spanish producer price inflation accelerated to a new record high of 46.6% year-over-year in March from a revised 41.2% in the earlier month.


Economics


The Chicago Fed National Activity Index fell to 0.44 in March from a revised reading of 0.54 in February.


The Federal Reserve Bank of Dallas' general business activity index for manufacturing in Texas fell to 1.1 in April from 8.7 in March.

Check out this: Goldman Sachs And 3 Other Stocks Insiders Are Selling


COVID-19 Update

The U.S. has the highest number of coronavirus cases and deaths in the world, reporting a total of 82,662,740 cases with around 1,018,330 deaths. India confirmed a total of at least 43,060,080 cases and 522,220 deaths, while Brazil reported over 30,349,460 COVID-19 cases with 662,700 deaths. In total, there were at least 509,613,690 cases of COVID-19 worldwide with more than 6,243,540 deaths.

Market News and Data brought to you by Benzinga APIs

© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.

To add Benzinga News as your preferred source on Google, click here.


Posted In:
EarningsNewsPenny StocksEurozoneCommoditiesSmall CapGlobalIntraday UpdateMarketsMid-Day Market Update
ARDX Logo
ARDXArdelyx Inc
$6.790.43%
Overview
KO Logo
KOCoca-Cola Co
$79.47-0.11%
NKTX Logo
NKTXNkarta Inc
$2.101.80%
SBFM Logo
SBFMSunshine Biopharma Inc
$1.16-0.33%
TBLT Logo
TBLTToughBuilt Industries Inc
$0.00020-100.0%
VTEX Logo
VTEXVtex
$3.03-%

Eliem Therapeutics, Inc. (NASDAQ:ELYM) shares tumbled 57% to $2.77 after the company announced the Phase 2a clinical trial of ETX-810 in diabetic peripheral neuropathic pain did not achieve the primary endpoint. The company also announced it elected to delay enrollment of its Phase 2a clinical trials of ETX-155 in major depressive disorder and perimenopausal depression.

ARDX Logo
ARDXArdelyx Inc
$6.790.43%
Overview
KO Logo
KOCoca-Cola Co
$79.47-0.11%
NKTX Logo
NKTXNkarta Inc
$2.101.80%
SBFM Logo
SBFMSunshine Biopharma Inc
$1.16-0.33%
TBLT Logo
TBLTToughBuilt Industries Inc
$0.00020-100.0%
VTEX Logo
VTEXVtex
$3.03-%
Comments
Loading...